Position in VERA
as of Jun 30, 2026
· filed Aug 14, 2026
Position Value
$11,957,214
+$149,830 QoQ
Shares Held
278,658
-5.1% QoQ
Ownership
0.387%
of shares outstanding
% of Portfolio
0.01%
of 13F equity value
Holder Rank
#47
of 217 holders
Holding Since
Jun 2021
17 quarters on record
Voting authority
Sole 100%
Shared 0%
None 0%
Common Shares in VERA Over Time
Shares Held
Position Value (USD)
Derivatives in VERA
reported options exposure · as of Mar 31, 2025CallValue
$372,310
CallShares
15,500
PutValue
$0
PutShares
0
Notional value of option positions as reported on Form 13F. Calls and puts are disclosed separately and do not net against the common-share stake above.
Position in Biotechnology
Healthcare · as of Jun 30, 2026MILLENNIUM MANAGEMENT LLC holds $4,595,633,334 across 322 Biotechnology names. VERA ranks #91 (0.3% of the industry book) .
| # | Ticker | Company | Shares | Value (USD) | Open |
|---|---|---|---|---|---|
| 1 | VRTX |
Vertex Pharmaceuticals Inc / Ma
|
468,410 | $232,673,299 | |
| 2 | INSM |
INSMED Inc
|
2,048,005 | $218,358,293 | |
| 3 | APGE |
Apogee Therapeutics, Inc.
|
1,491,404 | $197,954,052 | |
| 4 | JAZZ |
Jazz Pharmaceuticals plc
|
763,880 | $184,072,163 | |
| 5 | ONC |
BeOne Medicines Ltd.
|
543,323 | $154,830,755 | |
| 6 | AXSM |
Axsome Therapeutics, Inc.
|
556,088 | $136,113,659 | |
| 7 | BMRN |
Biomarin Pharmaceutical Inc
|
2,071,816 | $118,549,311 | |
| 8 | REGN |
Regeneron Pharmaceuticals, Inc.
|
165,120 | $102,958,924 |
All Filings in VERA
Export CSV
20 filing rows on record
| Report Date | Value (USD) | Shares | Type | Discretion | Filed | |
|---|---|---|---|---|---|---|
| 2026-06-30 | $11,957,214 | 278,658 | Shares | Sole | 2026-08-14 | |
| 2026-03-31 | $11,807,384 | 293,497 | Shares | Sole | 2026-05-15 | |
| 2025-12-31 | $10,113,972 | 199,723 | Shares | Sole | 2026-02-17 | |
| 2025-09-30 | $17,391,073 | 598,454 | Shares | Sole | 2025-11-14 | |
| 2025-06-30 | $5,155,658 | 218,831 | Shares | Sole | 2025-08-14 | |
| 2025-03-31 | $372,310 | 15,500 | Call | Sole | 2025-05-15 | |
| 2025-03-31 | $3,240,153 | 134,894 | Shares | Sole | 2025-05-15 | |
| 2024-12-31 | $3,283,733 | 77,648 | Shares | Sole | 2025-02-14 | |
| 2024-09-30 | $13,102,427 | 296,435 | Shares | Sole | 2024-11-14 | |
| 2024-06-30 | $1,208,303 | 33,397 | Shares | Sole | 2024-08-14 | |
| 2024-03-31 | $1,500,187 | 34,791 | Shares | Sole | 2024-05-15 | |
| 2023-06-30 | $5,355,708 | 333,689 | Shares | Sole | 2023-08-14 | |
| 2023-06-30 | $1,605,000 | 100,000 | Put | Sole | 2023-08-14 | |
| 2023-06-30 | $321,000 | 20,000 | Call | Sole | 2023-08-14 | |
| 2023-03-31 | $14,645,843 | 1,887,351 | Shares | Sole | 2023-05-15 | |
| 2022-12-31 | $21,452,358 | 1,108,649 | Shares | Sole | 2023-02-14 | |
| 2022-09-30 | $8,458,535 | 396,928 | Shares | Sole | 2022-11-14 | |
| 2022-06-30 | $3,759,667 | 276,243 | Shares | Sole | 2022-08-15 | |
| 2022-03-31 | $3,135,915 | 133,500 | Shares | Sole | 2022-05-16 | |
| 2021-06-30 | $1,080,053 | 81,452 | Shares | Sole | 2021-08-16 | |
| No filing history on record for this holder in this stock. | ||||||